The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CCDI-COG molecular characterization initiative: The expanding data on childhood cancer.
 
Erin Rudzinski
No Relationships to Disclose
 
Kareesma Parbhoo
No Relationships to Disclose
 
Nilsa Ramirez
No Relationships to Disclose
 
John Shern
No Relationships to Disclose
 
Rajkumar Venkatramani
No Relationships to Disclose
 
Sapna Oberoi
No Relationships to Disclose
 
Kenneth Chen
No Relationships to Disclose
 
Lauren Vasta
No Relationships to Disclose
 
Theodore Laetsch
Stock and Other Ownership Interests - Advanced Microbubbles
Consulting or Advisory Role - AI Therapeutics; Bayer; GlaxoSmithKline; ITM Oncologics; Jazz Pharmaceuticals
Research Funding - Adaptimmune (Inst); Advanced Accelerator Applications/Novartis (Inst); Bayer (Inst); BioAtla (Inst); Exelixis (Inst); ITM Oncologics (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Taiho Oncology (Inst); Turning Point Therapeutics (Inst)
 
Meredith Irwin
No Relationships to Disclose
 
Kelly Goldsmith
(OPTIONAL) Uncompensated Relationships - Abbvie/Genentech; Ymabs Therapeutics Inc
 
Diana Thomas
No Relationships to Disclose
 
Sarah Leary
Research Funding - Day One Therapeutics (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); PTC Therapeutics (Inst); Regeneron (Inst)
 
Maryam Fouladi
Research Funding - Bayer Schering Pharma (Inst); Bexion (Inst); Genentech (Inst); PTC therapeutics (Inst)
 
Douglas Hawkins
Research Funding - Bayer Health (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Pfizer (Inst)
 
Subhashini Jagu
Patents, Royalties, Other Intellectual Property - Richard Roden and Subhashini Jagu (2007): “Multitype HPV Peptide Compositions and Method for Treatment or Prevention of Human Papillomavirus Infection”.
 
Gregory Reaman
No Relationships to Disclose
 
Malcolm Smith
No Relationships to Disclose
 
Elaine Mardis
Consulting or Advisory Role - Scorpion Therapeutics
Speakers' Bureau - Bayer
 
Catherine Cottrell
No Relationships to Disclose